GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » Short Interest

Shionogi (TSE:4507) Short Interest


View and export this data going back to 1949. Start your Free Trial

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shionogi Short Interest Distribution

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Short Interest distribution charts can be found below:

* The bar in red indicates where Shionogi's Short Interest falls into.


Shionogi (TSE:4507) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » Short Interest
Comparable Companies
TSE:4523 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 TSE:4534 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
SGIOY:USA SGIOF:USA SH0:Germany
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
http://www.shionogi.co.jp
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (TSE:4507) Headlines

No Headlines